– Lansoprazole
How FIRST Kits help facilitate 503A and USP <795> compliance. + learn more
Users are encouraged to report adverse events to FDA MedWatch
1-800-FDA-1088 or at http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053074.htm
Azurity Pharmaceuticals™, Inc. was formerly known as CutisPharma®, Inc. Product packaging may reflect either name.
All product imagery is for representation purposes only - not actual labels.
© 2020 Azurity Pharmaceuticals™, Inc. All Rights Reserved.
